Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 Apr 27;302(6783):994-6.
doi: 10.1136/bmj.302.6783.994.

Terodiline with bladder retraining for treating detrusor instability in elderly people

Affiliations
Clinical Trial

Terodiline with bladder retraining for treating detrusor instability in elderly people

P A Wiseman et al. BMJ. .

Abstract

Objective: To compare terodiline with bladder retraining against placebo with bladder retraining in the treatment of detrusor instability in frail elderly patients.

Design: Randomised, double blind, parallel group study. Treatment lasted for six weeks. Frequency of micturition and episodes of incontinence recorded on diary chart by patients.

Setting: Incontinence clinic and a geriatric day hospital at two teaching hospitals.

Patients: 37 frail but ambulant patients, mean (range) age 80.4 (70-89) years with urinary frequency and urge incontinence, due to detrusor instability. Two patients withdrew before the first assessment (one in each group) and one could not complete the diary chart (placebo group).

Interventions: 19 patients received bladder retraining and terodiline 25 mg daily and 18 bladder retraining and placebo.

Main outcome measures: Change in urinary frequency and number of episodes of incontinence after six weeks' treatment. Patient's subjective evaluation of symptoms.

Results: Little difference was found in the results of treatment with terodiline and placebo. The change in episodes of incontinence per 24 hours was no different in the two groups (95% confidence interval -0.6 to 1.2; p = 0.75) and the difference between treatments in the change in frequency of micturition per 24 hours (-0.2) was not significant (-1.1 to 1.2; p = 0.76). Ten patients taking terodiline thought they had improved compared with seven receiving placebo; this difference was not significant.

Conclusion: Although the number of patients in each group was small and may have been insufficient to detect a drug effect, the possible benefit of terodiline is likely to be small.

PubMed Disclaimer

Comment in

References

    1. Scand J Urol Nephrol Suppl. 1984;87:35-47 - PubMed
    1. Scand J Urol Nephrol Suppl. 1984;87:21-33 - PubMed
    1. Eur J Clin Pharmacol. 1988;34(3):291-7 - PubMed
    1. Br J Urol. 1982 Aug;54(4):372-3 - PubMed

Publication types

LinkOut - more resources